MEDS · NASDAQ
DataMeds AI (MEDS) Stock Price & Fundamentals
DataMeds AI (MEDS) closed at $314.97 on Oct 9, 2026, down 0.73% from the previous close of $317.28.
Share price, past year
1Y +14.70%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $314.97 |
| Sep 30, 2026 | $316.54 |
| Aug 31, 2026 | $310.31 |
| Jul 31, 2026 | $290.89 |
| Jun 30, 2026 | $294.15 |
| May 29, 2026 | $290.23 |
| Apr 30, 2026 | $290.54 |
| Mar 31, 2026 | $290.09 |
| Feb 27, 2026 | $293.31 |
| Jan 30, 2026 | $285.59 |
| Dec 31, 2025 | $277.57 |
| Nov 28, 2025 | $290.79 |
| Oct 31, 2025 | $283.85 |
Key statistics
- Market cap
- $893.41M
- P/E (TTM)
- —
- EPS (TTM)
- −$2.61
- Revenue (TTM)
- $8.02M
- Net income (TTM)
- −$88.28M
- Shares outstanding
- 2.8M
- Dividend yield
- —
- 52-week range
- $268.85 – $321.28
DataMeds AI's market cap is $893.41M, based on a share price of $314.97 and 2.8M shares outstanding as of Jun 30, 2026.
Financials
DataMeds AI reported revenue of $23.34M for fiscal 2025, up 28.73% from fiscal 2024.
DataMeds AI reported a net loss of $101.27M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $23.34M | +28.7% | −$101.27M | −434.0% | −$1.43 | — |
| FY2024ended Dec 31, 2024 | $18.13M | — | −$6.86M | −37.8% | −$0.15 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.78M | −$18.36M | −$7.13 |
| Q1 FY2026ended Mar 31, 2026 | $1.56M | −$7.74M | −$0.07 |
| Q4 FY2025ended Dec 31, 2025 | $1.67M | −$27.85M | $5.05 |
| Q3 FY2025ended Sep 30, 2025 | $3.01M | −$34.32M | −$0.46 |
| Q2 FY2025ended Jun 30, 2025 | $7.79M | −$6.67M | −$5.40 |
| Q1 FY2025ended Mar 31, 2025 | $10.86M | −$32.43M | −$0.62 |
| Q3 FY2024ended Sep 30, 2024 | $5.67M | −$1.87M | −$0.04 |
| Q2 FY2024ended Jun 30, 2024 | $44.54K | — | — |
Company profile
- Name
- DataMeds AI, Inc.
- Ticker
- MEDS
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Headquarters
- 3000 Bayport Drive Suite 950, Tampa, FL 33607
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0002030763
Recent SEC filings
- Sep 17, 2026
- Sep 16, 2026
- Aug 18, 2026
- Aug 17, 2026
- Aug 14, 2026
- Aug 4, 2026
- Jul 29, 2026
- Jul 21, 2026
Frequently asked questions
What is DataMeds AI's stock price?
DataMeds AI (MEDS) closed at $314.97 on Oct 9, 2026, down 0.73% from the previous close of $317.28.
What is DataMeds AI's market cap?
DataMeds AI's market cap is $893.41M, based on a share price of $314.97 and 2.8M shares outstanding as of Jun 30, 2026.
How much revenue does DataMeds AI make?
DataMeds AI reported revenue of $23.34M for fiscal 2025, up 28.73% from fiscal 2024.
Does DataMeds AI pay a dividend?
DataMeds AI's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from DataMeds AI, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures